英格兰免疫功能正常成人带状疱疹急性并发症发生率:基于常规健康数据的匹配队列研究
该研究利用英国临床实践研究数据链(2001–2018年),在未接种疫苗的免疫功能正常成人中比较带状疱疹患者与年龄、性别和诊所匹配的无带状疱疹对照,量化急性非带状疱疹后神经痛(PHN)并发症风险。共纳入178 964例带状疱疹患者和1 799 380例对照,发现眼部、神经、皮肤、内脏及带状疱疹特异性并发症的归因风险均升高,且抗病毒治疗与神经并发症风险降低相关。
核心结论
- 带状疱疹非PHN并发症相对常见,可能影响带状疱疹疫苗接种的成本效果计算。
- 临床医生应意识到带状疱疹除PHN外还可导致多种并发症。
研究设计与样本
- 采用匹配队列研究,使用英国临床实践研究数据链2001至2018年常规健康数据。
- 研究对象为未接种疫苗的免疫功能正常成人带状疱疹 incident 病例及年龄、性别和诊所匹配的无带状疱疹对照。
- 共纳入178 964例带状疱疹病例和1 799 380例对照。
主要发现
- 归因风险在50岁以上患者中更高。
- 带状疱疹患者所有主要结局风险均高于对照。
临床怎么用
- 临床医生应关注带状疱疹患者除PHN外的急性并发症,尤其是眼部、神经、皮肤和内脏并发症。
- 对50岁以上患者应警惕更高的并发症归因风险。
- 急性期抗病毒治疗可能与降低神经并发症风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Herpes zoster can cause rare but serious complications; the frequency of these complications has not been well described. OBJECTIVES: To quantify the risks of acute non-postherpetic neuralgia (PHN) zoster complications, to inform vaccination policy. METHODS: We conducted a cohort study among unvaccinated immunocompetent adults with incident zoster, and age-, sex- and practice-matched control adults without zoster, using routinely collected health data from the UK Clinical Practice Research Datalink (years 2001 to 2018). Crude attributable risks of complications were estimated as the difference between Kaplan-Meier-estimated 3-month cumulative incidences in patients with zoster vs. controls. We used Cox models to obtain hazard ratios for our primary outcomes in patients with and without zoster. Primary outcomes were ocular, neurological, cutaneous, visceral and zoster-specific complications. We also assessed whether antivirals during acute zoster protected against the complications. RESULTS: In total 178 964 incident cases of zoster and 1 799 380 controls were included. The absolute risks of zoster-specific complications within 3 months of zoster diagnosis were 0·37% [95% confidence interval (CI) 0·34-0·39] for Ramsay Hunt syndrome, 0·01% (95% CI 0·0-0·01) for disseminated zoster, 0·04% (95% CI 0·03-0·05) for zoster death and 0·97% (95% CI 0·92-1·00) for zoster hospitalization. For other complications, attributable risks were 0·48% (95% CI 0·44-0·51) for neurological complications, 1·33% (95% CI 1·28-1·39) for ocular complications, 0·29% (95% CI 0·26-0·32) for cutaneous complications and 0·78% (95% CI 0·73-0·84) for visceral complications. Attributable risks were higher among patients > 50 years old. Patients with zoster had raised risks of all primary outcomes relative to controls. Antiviral prescription was associated with reduced risk of neurological complications (hazard ratio 0·61, 95% CI 0·53-0·70). CONCLUSIONS: Non-PHN complications of zoster were relatively common, which may affect cost-effectiveness calculations for zoster vaccination. Clinicians should be aware that zoster can lead to various complications, besides PHN.
引用
- Forbes HJ, Bhaskaran K, Grint D, et al. Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data. Br J Dermatol. 2021. PMID: 33216946. doi:10.1111/bjd.19687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。